How functional beverage brands can build trust and loyalty

Do GLP-1s have a future in Europe?

GLP-1 drugs have not shown as strong an uptake in Europe as in the US. What are the barriers to adoption? Large-scale consumer scepticism in countries such as France, Spain and especially Italy could work against uptake of the drugs, as could wariness of some health...
Menu